# Prospective Study on Severe Infections on Acute Myeloid Leukemia (AML) Patients

> **NCT01570465** · — · TERMINATED · sponsor: **Gruppo Italiano Malattie EMatologiche dell'Adulto** · enrollment: 144 (actual)

## Conditions studied

- AML
- Adult

## Interventions

- **OTHER:** Observation

## Key facts

- **NCT ID:** NCT01570465
- **Lead sponsor:** Gruppo Italiano Malattie EMatologiche dell'Adulto
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2012-09-11
- **Primary completion:** 2017-05-28
- **Final completion:** 2019-05-05
- **Target enrollment:** 144 (ACTUAL)
- **Why stopped:** low interest
- **Last updated:** 2022-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01570465

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01570465, "Prospective Study on Severe Infections on Acute Myeloid Leukemia (AML) Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01570465. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*